These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34651027)
1. Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice. Dai S; Liu F; Ren M; Qin Z; Rout N; Yang XF; Wang H; Tomlinson S; Qin X Front Cardiovasc Med; 2021; 8():731315. PubMed ID: 34651027 [No Abstract] [Full Text] [Related]
2. Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement. Narang A; Qiao F; Atkinson C; Zhu H; Yang X; Kulik L; Holers VM; Tomlinson S J Neuroinflammation; 2017 Jun; 14(1):120. PubMed ID: 28629465 [TBL] [Abstract][Full Text] [Related]
3. A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury. Li C; Patel K; Tu Z; Yang X; Kulik L; Alawieh A; Allen P; Cheng Q; Wallace C; Kilkenny J; Kwon J; Gibney B; Cantu E; Sharma A; Pipkin M; Machuca T; Emtiazjoo A; Goddard M; Holers VM; Nadig S; Christie J; Tomlinson S; Atkinson C Am J Transplant; 2021 Jun; 21(6):2067-2078. PubMed ID: 33210808 [TBL] [Abstract][Full Text] [Related]
4. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice. Banda NK; Tomlinson S; Scheinman RI; Ho N; Ramirez JR; Mehta G; Wang G; Vu VP; Simberg D; Kulik L; Holers VM Front Immunol; 2020; 11():575154. PubMed ID: 33178202 [TBL] [Abstract][Full Text] [Related]
5. Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice. Liu F; Wu L; Wu G; Wang C; Zhang L; Tomlinson S; Qin X Atherosclerosis; 2014 May; 234(1):237-43. PubMed ID: 24685815 [TBL] [Abstract][Full Text] [Related]
6. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury. Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397 [TBL] [Abstract][Full Text] [Related]
7. Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. Regal JF; Strehlke ME; Peterson JM; Wing CR; Parker JE; Nieto NF; Bemis LT; Gilbert JS; Fleming SD Mol Immunol; 2016 Oct; 78():38-47. PubMed ID: 27588825 [TBL] [Abstract][Full Text] [Related]
8. Natural immunoglobulin M initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration in mice. Marshall K; Jin J; Atkinson C; Alawieh A; Qiao F; Lei B; Chavin KD; He S; Tomlinson S Hepatology; 2018 Feb; 67(2):721-735. PubMed ID: 28880403 [TBL] [Abstract][Full Text] [Related]
9. Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope. Zheng C; Sleiman MM; Yang X; He S; Atkinson C; Tomlinson S J Heart Lung Transplant; 2021 Oct; 40(10):1112-1121. PubMed ID: 34334299 [TBL] [Abstract][Full Text] [Related]
10. A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage. Hatchell D; Alshareef M; Vasas T; Guglietta S; Borucki D; Guo C; Mallah K; Eskandari R; Tomlinson S J Neuroinflammation; 2023 Jun; 20(1):143. PubMed ID: 37322469 [TBL] [Abstract][Full Text] [Related]
11. A single-chain antibody construct with specificity of a natural IgM antibody reduces hepatic ischemia reperfusion injury in mice. Yang Z; Li C; Wang Y; Dong W; Yang M; Jin J J Cell Mol Med; 2024 Apr; 28(8):e18291. PubMed ID: 38597412 [TBL] [Abstract][Full Text] [Related]
12. A Role for P-selectin and Complement in the Pathological Sequelae of Germinal Matrix Hemorrhage. Hatchell D; Alshareef M; Vasas T; Guglietta S; Borucki D; Guo C; Mallah K; Eskandari R; Tomlinson S Res Sq; 2023 Feb; ():. PubMed ID: 36909595 [No Abstract] [Full Text] [Related]
13. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury. Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152 [TBL] [Abstract][Full Text] [Related]
14. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy. Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880 [TBL] [Abstract][Full Text] [Related]
15. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice. Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232 [TBL] [Abstract][Full Text] [Related]
16. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice. Guo Z; Chen J; Zeng Y; Wang Z; Yao M; Tomlinson S; Chen B; Yuan G; He S Front Immunol; 2021; 12():785287. PubMed ID: 35069557 [TBL] [Abstract][Full Text] [Related]